中国药物警戒 ›› 2026, Vol. 23 ›› Issue (6): 702-706.
DOI: 10.19803/j.1672-8629.20260130

• 综述 • 上一篇    下一篇

中药常山减毒控毒研究进展

马丽娜, 顾媛媛*, 刘文静, 何婷, 赵薇, 曹俊岭   

  1. 北京中医药大学东方医院药学部,北京 100078
  • 收稿日期:2026-02-12 出版日期:2026-06-15 发布日期:2026-06-18
  • 通讯作者: *顾媛媛,女,硕士,主任药师,中药合理用药。E-mail: guyy82@sina.com
  • 作者简介:马丽娜,女,博士,副主任药师,中药毒理学。
  • 基金资助:
    国家自然科学基金资助项目(82104518); 中央高水平中医医院临床科研业务费资助项目(00372026211101)

Research Progress on Reducing Toxicity and Controlling Toxicity in the Traditional Chinese Medicine Dichroae Radix

MA Lina, GU Yuanyuan*, LIU Wenjing, HE Ting, ZHAO Wei, CAO Junling   

  1. Department of Pharmacy, Dongfang Hospital, Beijing University of Chinese Medicine, Beijing 100078, China
  • Received:2026-02-12 Online:2026-06-15 Published:2026-06-18

摘要: 目的 系统梳理常山古今减毒方法,探讨其减毒规律与有效策略,为建立基于“毒效一体”特点的常山减毒控毒工艺提供参考。方法 整理分析历代古籍中记载的常山炮制、配伍、辨证用药等减毒方法,结合现代炮制工艺、毒效关系及联合用药减毒相关研究,进行归纳与对比分析。结果 古籍记载的减毒方法以炮制、配伍为主,炮制方式从酒制逐步发展为多种辅料共制。现代研究明确了喹唑酮类生物碱既是常山抗疟等功效的活性成分,也是其主要毒性物质基础,呈现出典型的“毒效一体”特征。实验证实炮制可降低常山碱含量,配伍可缓解其呕吐等毒性反应,并揭示了相关减毒机制。结论 常山减毒方法历史悠久且形式多样,传统经验与现代研究的结合为其临床安全应用奠定了基础。深入阐明“毒效一体”活性成分减毒增效的物质基础与作用靶点,并结合现代制剂技术优化工艺,有望推动常山的现代化开发与精准应用。

关键词: 常山, 喹唑酮, 生物碱, 截疟, 炮制, 配伍, 减毒, 增效

Abstract: Objective To collate the ancient and modern toxicity reduction methods of Dichroa Radix, explore the regularities and effective strategies for toxicity reduction, thereby providing a reference for establishing a toxicity-reduction and control process for Dichroa Radix based on its unique “toxicity-efficacy”characteristics. Method By collating the toxicity-reducing methods for Dichroa Radix recorded in ancient medical classics, including processing, compatibility, and syndrome-based medication, as well as, combining them with modern processing techniques, studies on the toxicity efficacy relationship, and combination drug toxicity reduction research, the relevant data were analyzed. Results The toxicity-reducing methods recorded in ancient texts primarily involved processing and compatibility. The processing methods gradually evolved from wine-processing to the combined use of multiple excipients. Modern studies have clearly indicated that quinazolinone alkaloids are not only the active components responsible for the antimalarial and other therapeutic effects of Dichroa Radix, but also the main toxic substrates, exhibiting a typical characteristic of “integration of toxicity and efficacy.” Experimental evidence has confirmed that processing can reduce the content of febrifugine, while compatibility can alleviate adverse reactions such as vomiting, and the related toxicity-reducing mechanisms have been elucidated. Conclusion The methods for reducing the toxicity of Dichroa Radix have a long history and diverse forms. The integration of traditional experience with modern research has laid a foundation for its safe clinical application. A thorough elucidation of the molecular basis and target underlying the reduction of toxicity and enhancement of efficacy in active ingredients characterized by the “integration of toxicity and efficacy”, combined with modern formulation technologies to optimize manufacturing processes, is helpful for advancing the modern development and precise application of Dichroa Radix.

Key words: Dichroae Radix, Quinazolinone, Alkaloids, Antimalarial, Processing, Compatibility, Toxicity Reduction, Efficacy Enhancement

中图分类号: